U.S. Metals and Mining Stock News

ProFrac Holding (ACDC) stock is in focus after first quarter 2026 results showed sales of US$449.6 million and a net loss of US$83.5 million, with revenue exceeding analyst expectations. See our latest analysis for ProFrac Holding. The earnings surprise and wider loss have coincided with a 7.71% 1 day share price return decline and a 12.73% 7 day share price return decline. However, the 62.87% year to date share price return and 65.53% 1 year total shareholder return suggest earlier momentum...

In the first quarter of 2026, Elanco Animal Health reported revenue of US$1,371 million versus US$1,193 million a year earlier, while net income eased to US$57 million from US$67 million and earnings per share from continuing operations slipped to US$0.11. Alongside raising full-year 2026 revenue guidance to a range of US$5.01 billion to US$5.09 billion and issuing second-quarter revenue guidance of US$1,300 million to US$1,325 million, Elanco highlighted innovation-led growth from products...

Why AerCap’s new buyback and guidance matter for investors AerCap Holdings (NYSE:AER) is back in focus after reporting a record quarter for aviation leasing, lifting its 2026 adjusted earnings guidance and authorizing a fresh US$1.0b share repurchase program. The results highlight how management is using higher earnings, strong demand for aircraft assets and cash generation to return capital through both buybacks and a US$0.40 quarterly dividend, while several analysts reassess their views on...

Recent share performance and business snapshot Newmark Group (NMRK) has drawn fresh attention after recent share price moves, with the stock showing a 1.6% return over the past day and 4.7% over the past week, alongside a 15.2% return over the past month. Over the past 3 months, Newmark Group’s return has been close to flat at 0.1%. Year to date, the stock shows a 0.6% decline, set against a 50.3% total return over the past year and a 3 year total return multiple of roughly 2.3x. At a last...

Veralto (VLTO) has been in focus after reporting first quarter 2026 results alongside a completed share buyback, giving investors fresh data on sales, profitability, and how management is deploying capital. See our latest analysis for Veralto. Despite the solid first quarter update and the completion of the share repurchase program, Veralto’s recent share price return has been muted. The 1-day share price return of 2.13% contrasts with a year-to-date share price return decline of 9.92% and a...

In early May 2026, Expedia Group reported Q1 2026 results with US$3,426 million in sales, a US$6 million net loss, confirmed its 2026 revenue outlook, announced a new up to US$5 billion share repurchase authorization after completing a prior US$4.13 billion buyback, and affirmed a US$0.48 quarterly cash dividend payable on June 18, 2026. An interesting angle is how Expedia is pairing strong Q1 earnings and AI-driven efficiency gains with substantial capital returns through large-scale...

Boise Cascade (BCC) is back in focus after first quarter 2026 results showed lower sales and net income versus a year earlier, even as the company exceeded revenue and EPS expectations and issued cautious EBITDA guidance. See our latest analysis for Boise Cascade. At a share price of US$72.76, Boise Cascade has seen recent share price pressure, with a 7 day share price return of 8.21% and a 90 day share price return of 20.07%. The 1 year total shareholder return of 17.92% contrasts with...

If you are wondering whether Revvity at around US$98.85 is offering value or is simply noise in your watchlist, this breakdown can help frame what the current price might be implying. The stock has been active recently, with returns of 14.1% over 7 days, 12.6% over 30 days, 0.7% year to date and 6.7% over 1 year, alongside longer term returns of a 15.8% decline over 3 years and a 29.2% decline over 5 years. These mixed returns indicate short term optimism combined with longer term caution,...

In early May 2026, Artivion, Inc. reported first‑quarter revenue of US$116.34 million, up from US$98.98 million a year earlier, and moved from a small net loss to a net income of US$1.42 million while also announcing plans to acquire Endospan following FDA approval of the NEXUS Aortic Arch System. Despite this topline growth and portfolio expansion, Artivion missed profit expectations and lowered its full‑year 2026 revenue and adjusted EBITDA guidance, highlighting near‑term operational...

Why Madison Square Garden Sports (MSGS) is Back on Investor Radars Madison Square Garden Sports (MSGS) stock has been drawing fresh attention after posting annual revenue of US$1,071.0 million and net income of US$16.6 million, prompting investors to reassess how this professional sports company is currently valued. See our latest analysis for Madison Square Garden Sports. At a share price of US$332.52, Madison Square Garden Sports has seen a 19.06% 90 day share price return and a 74.18% 1...

In early May 2026, Gilead Sciences reported first-quarter revenue of US$6.96 billion and net income of US$2.02 billion, while also completing a multi-year US$4.57 billion share repurchase program and filing a US$6.51 billion shelf registration for up to 47,750,000 common shares. At the same time, the FDA accepted Gilead’s New Drug Application for its once-daily bictegravir/lenacapavir HIV regimen with priority review, underscoring how strong HIV portfolio performance and an advancing...

Why Crane NXT stock is back in focus after Q1 Crane NXT (CXT) is drawing fresh attention after first quarter 2026 revenue and adjusted earnings topped expectations, helped by the Antares Vision acquisition and firm demand in Security and Authentication Technologies. See our latest analysis for Crane NXT. The latest results and acquisition update have arrived after a mixed share price run, with a 30 day share price return of 5.40% but a 1 year total shareholder return decline of 12.80%. If Q1...

BlackLine, Inc. recently reported first-quarter 2026 results, with GAAP revenue of US$183.16 million and net income of US$8.13 million, and issued guidance calling for second-quarter GAAP revenue of US$186 million to US$188 million and full-year 2026 GAAP revenue of US$765 million to US$769 million. Management’s decision to raise full-year guidance and highlight growing adoption of its AI-powered financial automation platform underlines how operational progress is increasingly shaping...

CarGurus, Inc. has now reported its past first-quarter 2026 results, posting sales of US$243.56 million versus US$212.24 million a year earlier, while net income eased to US$32.23 million from US$39.05 million and diluted EPS from continuing operations slipped to US$0.34 from US$0.40. Alongside this, CarGurus highlighted AI-led product investment, broader premium-tier adoption, a multi-year NASCAR Canada partnership, new data-driven Confidence Awards, and ongoing share repurchases,...

In April 2026, NRSInsights, an IDT Corporation subsidiary, reported a 3.9% year-over-year increase in same-store sales and a 13% rise in transaction values to US$2.20 billion, while chairman Howard S. Jonas disclosed several bona fide gifts of Class B Common Stock. The combination of stronger retail sales metrics at NRS and insider gifting activity underscores the growing operational weight of IDT’s retail data and payments platform within the group. We’ll now examine how NRSInsights’...

Zymeworks Inc. recently reported first-quarter 2026 results showing a wider net loss of US$44.16 million and a basic loss per share of US$0.59 as lower milestone revenue weighed on earnings. At the same time, the company underscored its upcoming August 2026 FDA Priority Review decision for zanidatamab and a cash runway it expects to extend beyond 2028, supported by royalty financing and share repurchases. Now we will examine how the widened quarterly loss alongside the imminent zanidatamab...

Houlihan Lokey (HLI) is back in focus after reporting record fiscal 2026 revenue, announcing a higher quarterly dividend, and posting a fourth quarter that missed analyst earnings and revenue expectations, creating a mixed signal for investors. See our latest analysis for Houlihan Lokey. The share price reaction reflects this mixed message, with a 1 day share price return of 4.26% after the earnings and dividend news, but a year to date share price decline of 12.95% alongside a 5 year total...

In early May 2026, Driven Brands Holdings Inc. disclosed that it would miss the SEC deadline for filing its Q1 2026 Form 10-Q as it continues restating prior years’ financial statements following the discovery of material accounting errors and internal control weaknesses. This delay, combined with a series of securities class action lawsuits alleging misleading financial reporting and ineffective controls, places Driven Brands’ governance and financial transparency under intense scrutiny...

In the past quarter, MasterBrand, Inc. reported Q1 2026 sales of US$618 million, down from US$660.3 million a year earlier, and moved from a net income of US$13.3 million to a net loss of US$15.4 million. Alongside weaker results, the company guided to a further mid- to high-single-digit year-over-year sales decline for Q2 2026 and confirmed it repurchased 226,914 shares under its 2025 buyback plan while advancing cost cuts and tariff mitigation as it works toward a merger with American...

Braze (BRZE) has announced a series of senior leadership moves, with Chief Financial Officer Isabelle Winkles set to leave after the current quarter, while Chief Accounting Officer Pankaj Malik steps in as interim CFO. See our latest analysis for Braze. At a share price of US$22.60, Braze has a 90 day share price return of 27.04%, set against a year to date share price decline of 30.57% and a 1 year total shareholder return decline of 32.86%. This suggests that recent momentum has picked up...

Clinical data spotlight on cardiac technologies Boston Scientific (BSX) is back in focus after new clinical results for its FARAPULSE PFA and WATCHMAN LAAC platforms were presented at Heart Rhythm 2026, bringing real world atrial fibrillation and stroke risk reduction outcomes to investors. See our latest analysis for Boston Scientific. Despite the encouraging clinical headlines and corporate activity around governance changes, institutional ownership updates and a new US$565.7m shelf...

PC Connection, Inc. reported past first-quarter 2026 results with sales of US$721.87 million and net income of US$17.22 million, alongside basic earnings per share of US$0.68 from continuing operations. On the same day, the company’s Board affirmed its capital return approach by declaring a US$0.20 per-share quarterly dividend, reinforcing the link between recent earnings strength and ongoing shareholder payouts. With this combination of stronger quarterly earnings and a maintained US$0.20...

EverCommerce Inc. reported past first-quarter 2026 results with revenue of US$147.47 million versus US$142.27 million a year earlier, and net income of US$7.17 million versus a net loss of US$7.71 million. The company highlighted growing uptake of its AI-enabled solutions and continued share repurchases, underscoring management’s focus on efficiency, higher-margin offerings, and capital returns. We’ll now examine how stronger profitability and accelerating adoption of AI-powered products...

Hayward Holdings (HAYW) drew fresh attention after reporting first quarter results, with sales of US$255.22 million and net income of US$23.36 million, alongside higher full year 2026 sales and earnings guidance. See our latest analysis for Hayward Holdings. Despite the stronger first quarter and higher 2026 guidance, Hayward Holdings’ 1-day and 7-day share price returns of 1.01% and 1.60% contrast with a 9.08% 1-month gain, while 1-year and 3-year total shareholder returns of 5.12% and...